Navigation Links
Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock
Date:11/8/2007

REDWOOD CITY, Calif., Nov. 8 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced the pricing of an underwritten public offering of 1,500,000 shares of its common stock for sale by Cardica and 2,579,795 shares of its common stock for sale by a selling stockholder, at a price to the public of $8.50 per share. Cardica also granted the underwriters a 30-day option to purchase up to an additional 611,969 shares of common stock from Cardica to cover over-allotments, if any. Cardica will not receive any proceeds from the sale of shares by the selling stockholder.

William Blair & Company, L.L.C. is acting as the sole book-running manager of the offering. Allen & Company LLC, Needham & Company, LLC and Merriman Curhan Ford & Co. will act as co-managers of the offering.

These shares are being issued pursuant to an effective shelf registration statement. This press release does not constitute an offer to sell or a solicitation of an offer to buy nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Printed copies of the final prospectus supplement and base prospectus relating to the offering may be obtained, when available, from William Blair & Company, L.L.C., Prospectus Department, 222 West Adams Street, Chicago, Illinois 60606, (312) 236-1600. Cardica intends to file a final prospectus supplement relating to the offering with the SEC, which will be available along with t
'/>"/>

SOURCE Cardica, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardica Announces Proposed Public Offering of Common Stock
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., TORONTO,Nov.25/PRNewswire/-SentinelleMedica...cedvisualizationsoftwarelaunchesasuiteofnewleading...ngsoftwareplatformatthisyear,sRadiologicalSocietyo...ec.5,2009(Booth5800,HallA).Theapplicationsleverage...pecializedMRIimagingcoilsandsupportmultipleimaging...
(Date:11/25/2009)..., LOSANGELES,Nov.25/PRNewswire-USNewswire/--T...ctionstodetermineexecutiveleadershipfor2010. ,,...withspecialtiesinpublicpolicy,law,finance,governme...ship.TheBoardalsocomesfromawiderangeofpersonalback...omen,somelivingwithHIVthemselves,andrepresentingmu...
(Date:11/25/2009)... Long-term survivors of testicular cancer who were...e severe side effects, including neurological side...were not treated with chemotherapy, according to a...urnal of the National Cancer Institute . , Maria...ukeland University Hospital, in Bergen, Norway, an...
(Date:11/25/2009)... Does stress increase blood pressure? This simple...or many years. New Stress-related gene Modulates ...crease blood pressure? This simple question has b... Now new research has for the first time establish... blood pressure response to stress in mice as well...
(Date:11/25/2009)... Evaluation and treatment ... Woodstock (Vocus) November 25, 2009 -- ... nasal vaccines and H1N1 vaccine shots at four Cen... another shipment of vaccine has arrived. The clin...l Lake and McHenry and will be open as follows: , ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ormerly of Harvard University,s Office of General ... All Legal Aspects of the Company, WALTHAM, Mass....leading research and advisory firms for pharmaceut...ny. Ms.,Silver comes to Decision Resources with an...
...URLINGTON, Mass., July 24 Palomar Medical,Technol...of laser- and,light-based devices for hair removal...terly conference call of its 2008 second quarter f...Time on,that day. The telephone replay will be ava...
... Chicago, 24 July 2008 The editors of Neurothera...uly issue, devoted to "Novel Therapeutics for Alzh...neurotherapeutics.org/ ) is the journal of the Ame...nference on Alzheimer,s Disease (ICAD), being held...
...Mark,s Breathe Easy Tour, Inspires Those with Chro...Enjoy Life, SAN DIEGO, July 24 SeQual Technologi...rk,s Breathe Easy Tour," a,SeQual-sponsored initia...h as chronic obstructive pulmonary,disease (COPD)....
...ATESVILLE, Ind., July 24 Hill-Rom Holdings,Inc.,s...release will be,issued Wednesday, August 6, 2008. ...following morning on Thursday, August 7, 2008 at 8...eased to,the public after the NYSE close on Wednes...
...EXICO CITY, July 24 New research from the Journal...issue on HIV/AIDS will be,released to the media, c...Four of the world,s top HIV/AIDS researchers will ... is embargoed until,10 a.m. (CT) Sun., Aug. 3, 200...
Other Medicine News:Health News:Lori Silver Joins Decision Resources, Inc. as General Counsel 2Health News:Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008 2Health News:Neurotherapeutics presents special issue on new treatments for Alzheimer's disease 2Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 2Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 3Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 4Health News:Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast 2
(Date:11/25/2009)...ioTrendsResearchGroup,Inc.releasedWave1ofits Laun...phasesyndicatedmarketresearchprojecttrackingthelau...nchthroughthefirstsixmonthsofavailability.Eachwave...iqueDermatologistsandqualitativeinformationfromasu...aclestouse,typicalpatienttypes,productperceptions,...
(Date:11/25/2009)...ewswire/--AMPACFineChemicalsLLC(AFC),asubsidiaryof...todaythatitreceivedtheEnvironmentalResponsibilitya...ntalSummit,sponsoredbytheCaliforniaManufacturersan...entalAssociation(IEA)andtheChemicalIndustryCouncil...tigiousawardavailablefromallthreeorganizationsandg...
(Date:11/25/2009)...ortlinker.comannouncesthatanewmarketresearchreport...pment-AGlobalMarketPerspective ,, http://www...-A-Global-Market-Perspective.html ,, Risinginc...pingnationsisaprincipalfactorinfluencinggrowthinth...utbreastcancerhasallowedwomentocomeforwardfortheir...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 1Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 2Versus Technology Inc Announces Sale of Real Time Location Information System to the Chalmers P Wylie Veterans Clinic 47620 3Regado Biosciences Establishes Medical Advisory Board 12421 1Regado Biosciences Establishes Medical Advisory Board 12421 2Regado Biosciences Establishes Medical Advisory Board 12421 3BioMarin to Present at the Goldman Sachs Healthcare Conference 12418 1BioMarin to Present at the Goldman Sachs Healthcare Conference 12418 2
... ASCO Cancer Conference, NORTH HOLLYWOOD, Calif., ...ernational Myeloma Foundation (IMF)-supporting res...t for myeloma patients,families, researchers and ...o a Phase 3 multi- national clinical trial shows t...s the probability of,survival by 41%. The follow-u...
...June 05, 2007 /PRNewswire-FirstCall/ --,Nuvelo, In...preclinical study of novel monoclonal antibodies a...monstrate that NTB-A is a,potential new target for...ukemia and lymphomas. The study, entitled "The lym...nal antibody target for,leukemia and lymphoma ther...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4
.../Cuff is specifically designed to treat children's...ic benefits of controlled compression to minimize ...in. Due to the unique design of the cuff, it can b...of the patient. The Pediatric Ankle Cryo/Cuff is i...
...is designed to stabilize the knee in full extensio...es the knee with cushioned straps, and is shaped t...tension. Because of its stability, lightweight des... ideal for post-op stabilization.,The Knee Immobi...
Front Closure Clavicle Support
Shoulder Stabilizer
Medicine Products: